RAFFA WEALTH MANAGEMENT, LLC’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$157 Buy
2
+1
+100% +$68 ﹤0.01% 1299
2026
Q1
$65 Buy
+1
New +$70 ﹤0.01% 1363
2022
Q4
Sell
-33
Closed -$1.3K 1105
2022
Q3
$1.3K Hold
33
﹤0.01% 718
2022
Q2
$1.45K Hold
33
﹤0.01% 693
2022
Q1
$1.32K Hold
33
﹤0.01% 761
2021
Q4
$1.33K Hold
33
﹤0.01% 778
2021
Q3
$1.34K Hold
33
﹤0.01% 727
2021
Q2
$1.5K Hold
33
﹤0.01% 705
2021
Q1
$1.38K Hold
33
﹤0.01% 740
2020
Q4
$1.41K Hold
33
﹤0.01% 646
2020
Q3
$867 Buy
33
+11
+50% +$306 ﹤0.01% 711
2020
Q2
$590 Buy
22
+8
+57% +$180 ﹤0.01% 784
2020
Q1
$252 Buy
+14
New +$266 ﹤0.01% 824

Other funds holding HALO

RAFFA WEALTH MANAGEMENT, LLC's HALO Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC increased its Halozyme (HALO) stake by 100% in Q2 2026, buying an estimated $68 and bringing the position to 2 shares worth $157. The position accounts for ﹤0.01% of the portfolio, ranked #1299.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in HALO in Q1 2020 and has held it in 13 quarters since. The position peaked at $1.5K in Q2 2021. 207 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • RAFFA WEALTH MANAGEMENT, LLC held 2 shares of Halozyme worth $157 as of Q2 2026.
  • RAFFA WEALTH MANAGEMENT, LLC bought 1 Halozyme share in Q2 2026, an estimated $68.
  • Halozyme made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #1299 holding.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in Halozyme in Q1 2020 and has held it in 13 quarters since.
  • RAFFA WEALTH MANAGEMENT, LLC's Halozyme position peaked at $1.5K in Q2 2021.
  • 207 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.